Cite

HARVARD Citation

    Harrison, C. et al. (n.d.). Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy. British journal of haematology. pp. 229-239. [Online]. 
  
Back to record